Diabetic Macular Edema (DME)
Showing 1 - 25 of 9,020
Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)
Not yet recruiting
- Diabetic Macular Edema
- EYP-1901
- Aflibercept 2Mg/0.05Ml Inj,Oph
- (no location specified)
Oct 19, 2023
Diabetic Macular Edema Trial in Austin (Experimental: Group 1, Experimental: Group 2, Experimental: Group 3)
Recruiting
- Diabetic Macular Edema
- Experimental: Group 1
- +3 more
-
Austin, TexasRezolute Investigative Site, Austin, TX
Jan 31, 2023
Safety and Effectiveness of Brolucizumab in Diabetic Macular
Not yet recruiting
- Diabetic Macular Edema
- brolucizumab
- (no location specified)
Jul 17, 2023
Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)
Recruiting
- Neovascular Age-related Macular Degeneration (NVAMD)
- Diabetic Macular Edema (DME)
-
Phoenix, Arizona
- +4 more
Jun 14, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Austin, TexasRetina Consultants of Austin
Jan 16, 2023
Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)
Not yet recruiting
- Diabetic Macular Edema (DME)
- Neovascular Age-Related Macular Degeneration (nAMD)
- aflibercept 8 mg PFS
- (no location specified)
Aug 3, 2023
Center Involved Diabetic Macular Edema, Diabetic Macular Edema Trial (OCU200 Low Dose, OCU200 Medium Dose, OCU200 High Dose)
Not yet recruiting
- Center Involved Diabetic Macular Edema
- Diabetic Macular Edema
- OCU200 Low Dose
- +2 more
- (no location specified)
Mar 27, 2023
Diabetic Macular Edema Trial (IBI324)
Not yet recruiting
- Diabetic Macular Edema
- IBI324
- (no location specified)
Aug 3, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)
Recruiting
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
-
Los Angeles, California
- +11 more
Jan 11, 2023
Describing DME, Their Patient Journey and Disease Progression
Not yet recruiting
- Diabetic Macular Edema
- (no location specified)
Jul 21, 2023
Diabetic Macular Edema Trial in Ahmedabad (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))
Not yet recruiting
- Diabetic Macular Edema
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Ahmedabad, Gujarat, IndiaRaghudeep Eye Hospital
Aug 19, 2022
Diabetic Macular Edema (DME) Trial in United States (AXT107 0.1 mg, AXT107 0.25 mg, AXT107 0.5 mg)
Active, not recruiting
- Diabetic Macular Edema (DME)
- AXT107 0.1 mg
- +2 more
-
Gilbert, Arizona
- +9 more
Jul 19, 2022
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Recruiting
- Diabetic Macular Edema
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)
Completed
- Diabetic Macular Edema
-
Beijing, Beijing, ChinaBeijing tongren hospital affliated to capital medical university
Apr 5, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in United States (AR-13503 Implant 10.6 Dose,
Completed
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- AR-13503 Implant 10.6 Dose
- +3 more
-
Gilbert, Arizona
- +5 more
Jun 9, 2022
Adult Diabetic Macular Edema and Suboptimal Response to
Not yet recruiting
- Diabetic Macular Edema
- (no location specified)
Jul 31, 2023
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),
Suspended
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Intravitreal injection of IBI302(dose 1)
- +3 more
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 17, 2023
Imaging Parameters and DME Treatment Response
Recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- No intervention
-
Durham, North CarolinaDuke Eye Center
Jan 3, 2023
Diabetic Macular Edema Trial in Al Qadisiyah (Phacoemulsification with IVI of aflibercept)
Completed
- Diabetic Macular Edema
- Phacoemulsification with IVI of aflibercept
-
Al Qādisīyah, Hawally, KuwaitAhady Hospital
Feb 14, 2023
Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)
Not yet recruiting
- Diabetic Macular Edema
- +8 more
-
Bakersfield, California
- +7 more
Aug 23, 2023
Diabetic Macular Edema, Diabetic Retinopathy Trial in Querétaro City, Queretaro (DME lactose pill, DME levosulpiride, DR lactose
Recruiting
- Diabetic Macular Edema
- Diabetic Retinopathy
- DME lactose pill
- +7 more
-
Querétaro City, Queretaro, Mexico
- +1 more
Oct 31, 2022
Learn More About How Well Aflibercept 8 mg Works in Treating
Not yet recruiting
- Visual Impairment
- +2 more
- Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Australia
- +5 more
Oct 4, 2023
Diabetic Macular Edema, Pars Plana Vitrectomy, Dexamethasone Intravitreal Implant Trial in Tianjin (Ozurdex, Aflibercept)
Not yet recruiting
- Diabetic Macular Edema
- +3 more
-
Tianjin, Tianjin, ChinaTianjin medical university eye hosipital
Aug 6, 2023